Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.890
-0.020 (-1.05%)
At close: Dec 5, 2025, 4:00 PM EST
1.880
-0.010 (-0.53%)
After-hours: Dec 5, 2025, 5:47 PM EST
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $179.27 million as of December 5, 2025. Its market cap has increased by 48.11% in one year.
Market Cap
179.27M
Enterprise Value
140.89M
1-Year Change
48.11%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $179.27M, an increase of 43.17%. That is a compound annual growth rate of 2.88%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |